Lv31
304 积分 2024-07-21 加入
A Patent Review on FDA‐Approved Antibody‐Drug Conjugates, Their Linkers and Drug Payloads
5小时前
待确认
Human Epidermal Growth Factor Receptor 2-Mutant Non-Small-Cell Lung Cancer: Continued Progress But Challenges Remain
13天前
已完结
Management of HER2 alterations in non-small cell lung cancer – The past, present, and future
13天前
已完结
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2− breast cancer: The LINUXtrial
14天前
已完结
Aiming at a Tailored Cure for ERBB2-Positive Metastatic Breast Cancer
1个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
1个月前
已完结
实体肿瘤治疗效果评价标准的研究进展
1个月前
已完结
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
1个月前
已完结
Association between quality of life and mortality risk in patients with breast cancer: a systematic review and meta-analysis
1个月前
已完结
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
2个月前
已完结
皖公网安备34019202002308
